Table 2 Median survival in days according to stage and number of cycles of chemotherapy
From: Treatment decisions and survival for people with small-cell lung cancer
Cycles | No. of patients (%) N =15 091 | Median survival from diagnosis (IQR) | No. of patients (%) N =7866 a | Median survival from completing chemotherapy (IQR) |
|---|---|---|---|---|
Overall | ||||
0 | 4509 (29.9) | 30 (14–74) | ||
1-2 | 2320 (15.4) | 85 (43–185) | 1595 (20.2) | 70 (24–191) |
3 | 908 (6.0) | 209 (125–377) | 818 (10.4) | 126 (50–300) |
4-5 | 3072 (20.4) | 316 (213–527) | 3000 (38.1) | 189 (95–405) |
≥6 | 2468 (16.4) | 377 (270–612) | 2453 (31.2) | 224 (114–453) |
NLCA onlyb | 1814 (12.0) | 230 (78–396) | ||
Extensive stage ( N =8293) 3972 | ||||
0 | 2891 (34.0) | 26 (12–56) | ||
1-2 | 1399 (16.9) | 73 (40–149) | 925 (23.8) | 53 (20–126) |
3 | 439 (5.3) | 163 (108–276) | 386 (9.7) | 82 (31–192) |
4-5 | 1432 (17.3) | 260 (187–384) | 1391 (35.0) | 135 (68–256) |
6 | 1280 (15.4) | 324 (247–485) | 1270 (32.0) | 168 (88–333) |
NLCA onlyb | 924 (11.1) | 177 (52–315) | ||
Limited stage ( N =3845) 2066 | ||||
0 | 715 (18.6) | 79 (25–218) | ||
1-2 | 465 (12.0) | 141 (58–366) | 346 (16.7) | 134 (50–383) |
3 | 295 (7.7) | 301 (177–552) | 276 (13.3) | 213 (97–461) |
4-5 | 1112 (28.9) | 420 (280–758) | 1098 (53.1) | 300 (154–648) |
6 | 777 (20.2) | 505 (342–843) | 774 (37.5) | 347 (183–690) |
NLCA onlyb | 484 (12.6) | 356 (199–586) | ||
